Volume 24, Number 4—April 2018
Research Letter
Cephalosporin-Resistant Neisseria gonorrhoeae Clone, China
Table
MICs of antimicrobial drugs for Neisseria gonorrhoeae isolates from 4 case-patients with cephalosporin-resistant NG-MAST G1407/MLST 1901 infections identified through the national Gonococcal Resistance Surveillance Program, China, 2015–2016*
Case-patient no. | MIC, mg/L |
||||||
---|---|---|---|---|---|---|---|
CRO | CFM | CIP | PEN | SPT | AZM | PPNG | |
1 | 0.5/R | 0.5/R | 8/R | 16/R | 16/S | 1/S | No |
2 | 0.5/R | 1/R | 32/R | 16/R | 32/S | 0.5/S | No |
3 | 0.5/R | 0.5/R | 32/R | 16/R | 32/S | 1/S | No |
4 | 0.25/R | 0.5/R | 32/R | 16/R | 64/S | 1/S | No |
*AZM, azithromycin; CFM, cefixime; CIP, ciprofloxacin; CRO, ceftriaxone; MLST, multilocus sequence type; NG-MAST, N. gonorrhoeae multiantigen sequence type; PEN, penicillin; PPNG, penicillinase-producing N. gonorrhoeae; R, resistant; S, susceptible; SPT, spectinomycin.
Page created: March 19, 2018
Page updated: March 19, 2018
Page reviewed: March 19, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.